Association of serum magnesium and calcium with metabolic syndrome: a cross-sectional study from the Qatar-biobank
- PMID: 39885554
- PMCID: PMC11783880
- DOI: 10.1186/s12986-024-00892-y
Association of serum magnesium and calcium with metabolic syndrome: a cross-sectional study from the Qatar-biobank
Abstract
Background and objectives: Metabolic syndrome (MetS) and its constituent comorbidities, along with mineral imbalances, pose a significant health burden in the Qatari population. Although Magnesium (Mg) and Calcium (Ca) have been individually linked to MetS, the impact of the calcium-to-magnesium ratio (Ca: Mg) on MetS remains unclear, especially in the adult population of Qatar. In this study, we aim to investigate the association between the total serum concentrations of Ca, Mg and Ca: Mg ratio with the outcome of MetS.
Methods: This comprehensive cross-sectional study included data on 9693 participants collected by Qatar Biobank (QBB). The serum levels of Mg and Ca, in addition to recorded metabolic parameters for the study participants, were used in the analyses. The presence of MetS was deemed as our primary outcome and its components as secondary outcomes. Logistic regression models were run to examine these associations.
Results and conclusion: MetS was present in more than 19% of the population. The mean serum Mg was higher in the non-MetS group 0.83 ± 0.06 mmol/L compared to the MetS group 0.81 ± 0.08 mmol/L. Conversely, the mean serum Ca and Ca: Mg ratio were higher in the MetS group (2.33 ± 0.09 mmol/L, 2.92 ± 0.36 mmol/L) compared to the non-MetS group (2.30 ± 0.08 mmol/L, 2.77 ± 0.23 mmol/L) respectively. In the context of MetS, we observed a negative dose-response relationship between Mg quartiles and MetS. In contrast, we found a positive association between Ca as well as Ca: Mg ratio and MetS.
Keywords: Calcium-to-magnesium ratio; Metabolic syndrome (MetS); Qatar biobank (QBB); Serum calcium (Ca); Serum magnesium (Mg).
© 2025. The Author(s).
Conflict of interest statement
Declarations. Competing interests: The authors declare no competing interests.
Figures

Similar articles
-
Association of low serum magnesium with diabetes and hypertension: Findings from Qatar Biobank study.Diabetes Res Clin Pract. 2019 Dec;158:107903. doi: 10.1016/j.diabres.2019.107903. Epub 2019 Oct 31. Diabetes Res Clin Pract. 2019. PMID: 31678625
-
Serum Magnesium and Cognitive Function Among Qatari Adults.Front Aging Neurosci. 2020 Apr 15;12:101. doi: 10.3389/fnagi.2020.00101. eCollection 2020. Front Aging Neurosci. 2020. PMID: 32351381 Free PMC article.
-
Relationship between serum calcium and magnesium concentrations and metabolic syndrome diagnostic components in middle-aged Korean men.Biol Trace Elem Res. 2012 Apr;146(1):35-41. doi: 10.1007/s12011-011-9224-5. Epub 2011 Oct 8. Biol Trace Elem Res. 2012. PMID: 21984404
-
Serum Magnesium is Inversely Associated with Body Composition and Metabolic Syndrome.Diabetes Metab Syndr Obes. 2023 Jan 12;16:95-104. doi: 10.2147/DMSO.S391369. eCollection 2023. Diabetes Metab Syndr Obes. 2023. PMID: 36760601 Free PMC article.
-
Dose-response relationship of serum ferritin and dietary iron intake with metabolic syndrome and non-alcoholic fatty liver disease incidence: a systematic review and meta-analysis.Front Nutr. 2024 Oct 1;11:1437681. doi: 10.3389/fnut.2024.1437681. eCollection 2024. Front Nutr. 2024. PMID: 39410926 Free PMC article.
Cited by
-
Intake or Blood Levels of Magnesium and Risk of Metabolic Syndrome: A Meta-Analysis of Observational Studies.Nutrients. 2025 May 14;17(10):1667. doi: 10.3390/nu17101667. Nutrients. 2025. PMID: 40431407 Free PMC article. Review.
-
Hypomagnesemia: exploring its multifaceted health impacts and associations with blood pressure regulation and metabolic syndrome.Diabetol Metab Syndr. 2025 Jun 16;17(1):217. doi: 10.1186/s13098-025-01772-y. Diabetol Metab Syndr. 2025. PMID: 40524199 Free PMC article. Review.
References
-
- Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640-5. - PubMed
-
- Ansarimoghaddam A, Adineh HA, Zareban I, Iranpour S, HosseinZadeh A, Kh F. Prevalence of metabolic syndrome in Middle-East countries: Meta-analysis of cross-sectional studies. Diabetes Metab Syndr. 2018;12(2):195–201. - PubMed
-
- Després JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature. 2006;444(7121):881–7. - PubMed
-
- Rahimlou M, Mirzaei K, Keshavarz SA, Hossein-Nezhad A. Association of circulating adipokines with metabolic dyslipidemia in obese versus non-obese individuals. Diabetes Metabolic Syndrome: Clin Res Reviews. 2016;10(1):S60–5. - PubMed
LinkOut - more resources
Full Text Sources